KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.85

Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study.

John A Snowden, Sam H Ahmedzai, Angela Cox, David A Cairns, A John Ashcroft, Cathy Williams, Jamie D Cavenagh, Anna Hockaday, Julia M Brown, Ian W Brock, Treen C M Morris, Gordon Cook, National Cancer Research Institute Haemato-oncology Clinical Studies Group

Bone Marrow Transplant 57(10) 1507-1513

PMID35768571
PMCIDPMC9532240
DOI10.1038/s41409-022-01738-y
发表日期2022-06-29
入排依据:The record is from a randomized Phase III trial in oncology (multiple myeloma) and includes a drug intervention (cyclophosphamide). However, the specific report is an exploratory, post-hoc analysis of genetic variants in relation to patient-reported quality of life and pain, not a primary efficacy result. It lacks any primary or key secondary time-to-event efficacy endpoint (e.g., OS, PFS, DFS, Kaplan-Meier, HR).
摘要

摘要

The Myeloma X trial provided a platform to explore genetics in relation to systematic assessment of patient-reported outcomes at key points during salvage treatment in multiple myeloma (MM) patients. Blood DNA was obtained in 191 subjects for single nucleotide polymorphism (SNP) genotyping. By univariable analysis, the non-coding rs2562456 SNP, upstream of LINC00664, was associated with several relevant pain and health-related quality-of-life (HRQoL) scores at 100 days after allocation to consolidation with autologous stem cell transplantation or weekly cyclophosphamide. Presence of the minor (C) allele was associated with lower pain interference (p = 0.014) and HRQoL pain (p = 0.003), and higher HRQoL global health status (p = 0.011) and physical functioning (p = 0.007). These effects were not modified by treatment arm and were no longer significant at 6 months. Following induction therapy, the rs13361160 SNP near the CCT5 and FAM173B genes was associated with higher global health (p = 0.027) and physical functioning (p = 0.013). This exploratory study supports associations between subjective parameters in MM with SNPs previously identified in genome-wide association studies of pain. Conversely, SNPs in candidate genes involved in opioid and transporter pathways showed no effect. Further studies are warranted in well-defined cancer populations, and potentially assisted by whole genome sequencing with germline analysis in routine diagnostics in haematological cancers.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。